We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$67.2B
AUM Growth
-$732M
Cap. Flow
-$4.09B
Cap. Flow %
-6.1%
Top 10 Hldgs %
8.84%
Holding
4,165
New
463
Increased
1,438
Reduced
1,417
Closed
409

Sector Composition

Rank Sector Weight
1 Healthcare 12.61%
2 Technology 9.11%
3 Communication Services 9.07%
4 Energy 8.1%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYE icon
3601
Myers Industries
MYE
$1.23B
$140K ﹤0.01%
10,531
-19,772
-65% -$287K
RCKY icon
3602
Rocky Brands
RCKY
$338M
$140K ﹤0.01%
+12,099
New +$148K
TTOO
3603
DELISTED
T2 Biosystems, Inc
TTOO
$140K ﹤0.01%
3
SN
3604
DELISTED
Sanchez Energy Corporation
SN
$140K ﹤0.01%
32,431
-27,999
-46% -$158K
NAVB
3605
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$138K ﹤0.01%
+5,172
New +$180K
CSR
3606
Centerspace
CSR
$905M
$137K ﹤0.01%
1,966
-1,298
-40% -$101K
NXRT
3607
NexPoint Residential Trust
NXRT
$624M
$137K ﹤0.01%
+10,465
New +$137K
VANI icon
3608
Vivani Medical
VANI
$128M
$137K ﹤0.01%
+966
New +$141K
CYTR
3609
DELISTED
CytRx Corp
CYTR
$134K ﹤0.01%
+8,409
New +$144K
PFNX
3610
DELISTED
Pfenex Inc.
PFNX
$132K ﹤0.01%
+10,668
New +$157K
BDBD
3611
DELISTED
BOULDER BRANDS INC
BDBD
$132K ﹤0.01%
+11,996
New +$117K
SLM icon
3612
CALL
SLM Corp
SLM
$4.98B
$130K ﹤0.01%
20,000
CMRX
3613
DELISTED
Chimerix, Inc.
CMRX
$130K ﹤0.01%
+14,500
New +$522K
HTGC icon
3614
Hercules Capital
HTGC
$3.29B
$129K ﹤0.01%
10,572
-103,554
-91% -$1.17M
LSTA icon
3615
Lisata Therapeutics
LSTA
$15.7M
$129K ﹤0.01%
795
+552
+227% +$101K
MTEM
3616
DELISTED
Molecular Templates, Inc.
MTEM
$129K ﹤0.01%
1,624
+51
+3% +$25.1K
I
3617
DELISTED
INTELSAT S. A.
I
$128K ﹤0.01%
30,888
-44,674
-59% -$248K
ANTH
3618
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$127K ﹤0.01%
+3,409
New +$150K
CNXR
3619
DELISTED
Connecture, Inc.
CNXR
$126K ﹤0.01%
34,990
+586
+2% +$2.47K
CDE icon
3620
PUT
Coeur Mining
CDE
$22.2B
$124K ﹤0.01%
50,000
-130,000
-72% -$355K
CENX icon
3621
Century Aluminum
CENX
$4.38B
$122K ﹤0.01%
+27,494
New +$118K
ARRY
3622
DELISTED
Array Biopharma Inc
ARRY
$121K ﹤0.01%
28,762
+1,603
+6% +$7.32K
JMEI
3623
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$120K ﹤0.01%
+1,324
New +$127K
BSBR icon
3624
Santander
BSBR
$43.4B
$117K ﹤0.01%
+31,442
New +$116K
KMI.WS
3625
DELISTED
Kinder Morgan Inc
KMI.WS
$117K ﹤0.01%
1,949,600

Similar funds

David Shaw's Q4 2015 Portfolio in Review

As of Q4 2015, David Shaw held 4,165 positions worth $67.2B, down 1.1% from $67.9B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

David Shaw withdrew a net $4.09B in Q4 2015, closing 409 positions and reducing 1,417 holdings. Its most notable exit was Altera Corp, an estimated $236M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Technology and Communication Services.

Against the trend, David Shaw opened a new position in Alphabet (Google) Class A worth $417M.

  • David Shaw's largest Q4 2015 buy was Alphabet (Google) Class A: 10,723,880 shares worth $417M.
  • David Shaw added most to Apple in Q4 2015, an estimated $483M increase.
  • David Shaw's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $632M.
  • David Shaw fully exited Altera Corp in Q4 2015, selling an estimated $236M.
  • David Shaw's ten largest holdings make up 8.8% of its $67.2B portfolio in Q4 2015.
  • David Shaw opened 463 new positions and closed 409 in Q4 2015.
  • David Shaw's portfolio value fell 1.1% quarter-over-quarter to $67.2B.

Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.